FATE

Fate Therapeutics, Inc.

Halal Rating :
Uncomfortable
See Details
Last Price $1.85 Last updated:
Market Cap $208.95m
7D Change 0.71%
1 Year Change -90.49%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing
Exchange NASDAQ
Next Earnings Date Nov. 2, 2023

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders globally. The company is headquartered in San Diego, California.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
June 30, 2023 $1.11m $63.5m $4.38m - 392.91% 0.00%
March 31, 2023 $58.98m $87.57m $3.69m $9.71m 6.26% 11.09%
Dec. 31, 2022 $44.36m $108.78m $2.88m $2.88m 6.49% 2.65%

Company Impact

Help us evaluate Fate Therapeutics, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Justification for our Halal Rating

Contribute

Recent News & Updates